Navigation Links
Nexavar Data to be Presented at 46th American Society of Clinical Oncology Annual Meeting
Date:5/20/2010

r, Houston, Texas
  • Abstract 7609, General Poster Session, Lung Cancer – Metastatic Track
  • Sunday, June 6, 2010, 8:00 a.m.-12:00 p.m., S Hall A2

  • Breast Cancer

    • Multivariate Analysis (MVA) of Progression-Free Survival (PFS) in 2 Phase 2b, Multinational, Double-Blind, Randomized, Placebo-Controlled Trials Evaluating Sorafenib Plus Standard Chemotherapy in Patients with HER-2 Negative Locally advanced or Metastatic Breast Cancer.
      • William John Gradishar, M.D., Northwestern University Feinberg School of Medicine, Chicago, Illinois
      • Abstract 1073, General Poster Session, Breast Cancer Track
      • Saturday, June 5, 2010, 2:00-6:00 p.m., S Hall A2
    • A Regional Subgroup Analysis of a Multinational, Double-Blind, Randomized, Placebo Controlled, Phase 2b Study Evaluating Sorafenib (SOR) with Paclitaxel (PAC) in Patients (pts) with Advanced Breast Cancer (BC).
      • Tarini Prasad Sahoo, M.D., Jawaharlal Nehru Cancer Hospital & Research Centre, Bhopal, India
      • Abstract 1114, General Poster Session, Breast Cancer Track
      • Saturday, June 5, 2010, 2:00-6:00 p.m., S Hall A2
    • Management of Hand-Foot Skin Reaction (HFSR)/Hand-Foot Syndrome (HFS) in SOLTI-0701: A Double-Blind, Randomized Phase 2b Study Comparing Sorafenib vs Placebo in Comb
      '/>"/>

    SOURCE Bayer HealthCare Pharmaceuticals, Inc.; Onyx Pharmaceuticals, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8

    Related biology technology :

    1. Onyx Pharmaceuticals Announces a Teleconference and Webcast to Provide an Update on Nexavar and Report Full Year 2007 Financial Results
    2. Bayer and Onyx Announce Nexavar Data Presentations at 44th American Society of Clinical Oncology Annual Meeting
    3. Onyx Pharmaceuticals Announces a Teleconference and Webcast to Provide an Update on Nexavar
    4. Bayer and Onyx Announce Nexavar Data Presentations at 45th American Society of Clinical Oncology Annual Meeting
    5. Three Studies by Independent Scientists Highlighting Pressure Cycling Technology (PCT) to be Presented this Week at the British Mass Spectrometry Societys 29th Annual Meeting
    6. Survival Data Presented From Phase II Study of Investigational Drug ZD4054 in Hormone-Resistant Prostate Cancer Patients
    7. New Data Presented on Immunocytokine Fusion Protein Further Supports Broad Anti-Cancer Potential Of Peregrines Anti-PS Technology Platform
    8. Results of Colon Cancer Study Utilizing Pressure Cycling Technology (PCT) Presented at the American College of Gastroenterology Annual Scientific Meeting
    9. Kuvan, Naglazyme and Aldurazyme Data to Be Presented at the 57th Annual Meeting of the American Society of Human Genetics
    10. Micromet Data Presented at the International AACR-NCI-EORTC Conference Support the Development of Adecatumumab (MT201) in Earlier Stage Cancer Disease Settings
    11. Three PDX (Pralatrexate) Studies Presented at the 2007 AACR-NCI-EORTC Conference
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:3/3/2015)... March 3, 2015  Neurocrine Biosciences, Inc. (Nasdaq: ... , President and Chief Executive Officer of Neurocrine Biosciences, ... in Miami.   The live presentation takes ... PT).  The presentation will be webcast and may be ... Listeners are encouraged to visit the ...
    (Date:3/3/2015)... Santa Clara, California (PRWEB) March 03, 2015 ... and development service company, has launched a new Life ... research reagents for preclinical research. , The first ... monoclonal antibody isotype controls, and soon to be released ... The company will continue to expand their life science ...
    (Date:3/3/2015)... 2015 HubCast® Inc. ( http://www.hubcast.com ), ... the expansion of its Global Print Supply Chain with ... the world’s largest cities across 75 countries globally. ... countries providing global enterprises ease, speed, reach, quality, cost ... online order to real-world delivery at postal address around ...
    (Date:3/3/2015)... March 3, 2015 AtheroNova Inc. (OTCQB: AHRO) today ... filed voluntary petitions under Chapter 11 of the U.S. Bankruptcy ... California , Santa Ana ... Chapter 11 cases are expected to be jointly administered. ... Court supervised asset sale process, for all or substantially all ...
    Breaking Biology Technology:Crown Bioscience Launches Life Science Product Catalog 2HubCast Expands Global Print Supply Chain: Launches New Product Suite 2HubCast Expands Global Print Supply Chain: Launches New Product Suite 3HubCast Expands Global Print Supply Chain: Launches New Product Suite 4AtheroNova and its Subsidiary File for Chapter 11 Bankruptcy Protection 2AtheroNova and its Subsidiary File for Chapter 11 Bankruptcy Protection 3AtheroNova and its Subsidiary File for Chapter 11 Bankruptcy Protection 4
    ... Senior Vice President, Commercial Development, NASHVILLE, ... appointed industry veteran Martin E. Cearnal as ... created position Mr.,Cearnal will be directly involved ... (Photo: http://www.newscom.com/cgi-bin/prnh/20080903/CLW115 ), ...
    ... 3 US Oncology Specialty, LP, the,state-of-the-art pharmaceutical ... Excellence Achievement Award from the National,Safety Council for ... presented to companies who produce the "best of ... eligible, organizations must report,days away from work resulting ...
    ... Sept. 3 eResearchTechnology,Inc. (eRT), (Nasdaq: ERES ... technology, ePRO and other services to the pharmaceutical,biotechnology, ... Michael J. McKelvey, the Company,s President and Chief ... Officer, are,scheduled to present at the Thomas Weisel ...
    Cached Biology Technology:Cumberland Pharmaceuticals Taps Industry Veteran for Key Executive Position 2US Oncology Pharmaceutical Distribution Service Wins National Safety Council Award 2eResearchTechnology, Inc. to Present at the Thomas Weisel Healthcare Conference on September 4th, 2008 2
    (Date:2/5/2015)... TRIANGLE PARK, North Carolina , 5. ... sein 35. Jahr als spezialisiertes Logistikunternehmen und ... Position als einzige klinische Logistikfirma (Clinical Logistics ... Die Kernbotschaft der neuen Kampagne lautet ... und Lieferungen. Foto: http://photos.prnewswire.com/prnh/20150205/173753 ...
    (Date:2/5/2015)... New Market Research Reports Title ... To 2020 has Been Added to GrandViewReseach.com Report Database ... to reach USD 5.10 billion by 2020, according to ... cameras help identify the site of tissue damage in ... demand in medical imaging applications. They have been extensively ...
    (Date:1/22/2015)... Jan. 22, 2015 Research and Markets ( http://www.researchandmarkets.com/research/4trb7t/biometrics_a ... A Global Market Overview" report to their offering. ... to ensure that an individual is who she/he is claiming ... use of a person,s unique physical characteristics, such as fingerprint, ...
    Breaking Biology News(10 mins):Marken startet Kampagne mit Patienten im Mittelpunkt 2Marken startet Kampagne mit Patienten im Mittelpunkt 3IR Camera Market Worth $5.10 Billion By 2020: Grand View Research, Inc. 2IR Camera Market Worth $5.10 Billion By 2020: Grand View Research, Inc. 3Biometrics - A Global Market Overview 2Biometrics - A Global Market Overview 3
    ... before 4 months of age and after 6 months may ... of Colorado researchers have found. The researchers, from the ... Medicine,s Barbara Davis Center for Diabetes, also found that the ... baby when solid foods, particularly those containing wheat or barley, ...
    ... indicate that our close cousins, the Neandertals, were much more ... did they have anything like modern speech and language? And ... diversity? The MPI for Psycholinguistics researchers Dan Dediu and Stephen ... Language Sciences that modern language and speech can be ...
    ... a better way to detect heat loss in electric-vehicle ... developed or advanced at the Energy Department,s National Renewable ... year,s most significant innovations by R&D Magazine. "These ... and energy efficiency demonstrate how NREL research produces results ...
    Cached Biology News:Infants' food linked to higher, lower Type 1 diabetes risk 2Did Neandertals have language? 2NREL research earns 3 prestigious R&D 100 Awards 2NREL research earns 3 prestigious R&D 100 Awards 3NREL research earns 3 prestigious R&D 100 Awards 4
    nuclear RNA export factor 1, mRNA...
    The Captivate Disposable Sample Chamber is designed for use with the Captivate magnetic yoke assembly (C-24700) and can be used with our Captivate ferrofluid conjugates (C-21473 C-21474 C-21476) or ...
    ... analysis of gene expression) technology ... Expression profiles generated by SAGE ... low-abundance transcripts making it possible ... I-SAGE Kit is designed to ...
    ... ultimate in utility and flexibility press-to-seal silicone ... needs of the researcher. They are available ... as sheet material that can be easily ... are autoclavable and non-cytotoxic and can be ...
    Biology Products: